SM, S., DE, W., DP, T., PE, P., S, F., GA, B., . . . DP, R. (2026). Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360, 7(5), 1192. https://doi.org/10.34067/KID.0000001230
Chicago Style (17th ed.) CitationSM, Sprague, et al. "Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study." Kidney360 7, no. 5 (2026): 1192. https://doi.org/10.34067/KID.0000001230.
MLA (9th ed.) CitationSM, Sprague, et al. "Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study." Kidney360, vol. 7, no. 5, 2026, p. 1192, https://doi.org/10.34067/KID.0000001230.
Warning: These citations may not always be 100% accurate.
